«Ulcerative Colitis

Below is an extended Ulcerative Colitis patents listing. Click here to return to the Ulcerative Colitis main in depth entry.

Patents :
US Patent No.	Title
7423115	ARTS C-terminus fragments and mimetics thereof
7425554	1,2-di(cyclic)substituted benzene compounds
7425555	Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
7425561	3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
7425567	Piperidine derivative compounds and drugs containing the compounds as the active ingredient
7425578	Immunoregulatory compounds and derivatives and methods of treating diseases therewith
7425580	(Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
7425619	Fc.gamma.RIIB specific antibodies and methods of use thereof
7425620	Fc.gamma.RIIB-specific antibodies and methods of use thereof
7425635	Prodrugs and conjugates of thiol- and selenol-containing compounds and methods of use thereof
7427391	Formulations for use in medical and diagnostic procedures
7425553	Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
7425546	Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
7425545	Modulation of C-reactive protein expression
7423116	Pentapeptide compounds and uses related thereto
7423129	Antibodies to human eotaxin
7423139	High level expression of recombinant human erythropoietin having a modified 5'-UTR
7423177	Carboxamide derivatives as therapeutic agents
7423185	Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
7425324	Antagonists of MCP proteins
7425325	Cytokine zcytor17 ligand polypeptides
7425330	Methods of inhibiting TNF.alpha. activity in the blood of a patient
7425331	Protein A methods of use
7425447	Host cells expressing 7C10 and 16C10 CD80-specific antibodies
7427403	Methods for inhibiting lymphotoxin .beta. receptor signalling
7427487	Constitutively active CXCR3 G protein-coupled chemokine receptor and modulators thereof for the treatment of inflammatory disorders
7429374	Process for the measurement of the potency of glatiramer acetate
7429384	Chimeric antagonist anth1
7429562	Cyclosporin analog formulations
7429570	Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
7429588	Crystalline isoxazole derivative and medical preparation thereof
7429594	Substituted heterocyclic compounds and methods of use
7429598	Spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
7429599	Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
7429615	Cyclohexyl prostaglandin analogs as EP.sub.4-receptor agonists
7429617	Phenoxyalkycarboxylic acid derivatives in the treatment of interstitial cystitis
7427685	Therapeutic substituted cyclopentanes
7427668	Antibodies binding the TNF related protein, TNF-Y
7427638	(+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminois- oindoline-1,3-dione:, and methods of synthesis and compositions thereof
7427494	Nucleic acid encoding cytokine receptor zcytor17
7427589	Use of cytokine inhibitors
7427595	Use of proepithelin to promote wound repair and reduce inflammation
7427605	Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
7427606	Method to reduce inflammatory response in transplanted tissue
7427611	Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them
7427625	Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
7427628	Heterocyclic compounds which inhibit leukocyte adhesion mediated by .alpha..sub.4 integrins
7427630	Condensed N-heterocyclic compounds and their use as CRF receptor antagonists
7427631	Metalloproteinase inhibitors
7429646	Antibodies to human tumor necrosis factor receptor-like 2

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.